Clinical Trial Update: A 12-Week Study of Topical Pirenzepine or Placebo in Type 2 Diabetic Patients (T2DM) With Painful Peripheral Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing topical pirenzepine to placebo in patients with painful diabetic neuropathy (type 2 diabetes) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Painful Diabetic Neuropathy

Drugs mentioned

• pirenzepine (topical) (pirenzepine)

Snippet

Sponsor: WinSanTor, Inc | Conditions: Painful Diabetic Neuropathy, Diabetes Mellitus | Phase 2 | Status: COMPLETED